Axim Biotechnologies, Inc.
AXIM- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001514946
No open-market purchases or sales by Axim Biotechnologies, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Axim Biotechnologies, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Axim Biotechnologies, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Valencia Catalina | President and Director | 28,608,220 | Oct 15, 2024 | 0 |
| Malasek Robert | Chief Financial Officer | – | Mar 19, 2024 | 0 |
| Huemoeller John Walter II | Chief Executive Officer | 6,000,000 | Mar 19, 2024 | 0 |
| Schroeder Blake | Director | 854,012 | Mar 19, 2024 | 0 |
| Cunningham Robert L | Director | – | Mar 19, 2024 | 0 |
| Scott Timothy Richard | Director | – | Mar 19, 2024 | 0 |
| O'Rourke Peter | Director | – | Mar 19, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 (view filing) | Jan 30 | 259 daysLate | Valencia CatalinaPresident and Director | PPurchase | +1.09M | – | – | +3.9%28.6M after | |
| Sep 23, 2022 (view filing) | Mar 19, 2020 | 918 daysLate | Huemoeller John Walter IIChief Executive Officer | PPurchase | +6.00M | – | – | New position6.00M after | |
| Aug 31, 2022 (view filing)4:01 PM ET | Aug 24 | 7 daysLate | Valencia Catalina10% Owner | PPurchase | +3.86M | $0.0259 | +$100.0K | +19.5%23.7M after |